These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 24966933)

  • 1. Inhibitory role of prohibitin in human ovarian epithelial cancer.
    Jia L; Ren JM; Wang YY; Zheng Y; Zhang H; Zhang Q; Kong BH; Zheng WX
    Int J Clin Exp Pathol; 2014; 7(5):2247-55. PubMed ID: 24966933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical localization of metallothionein in benign and malignant epithelial ovarian tumors.
    McCluggage WG; Strand K; Abdulkadir A
    Int J Gynecol Cancer; 2002; 12(1):62-5. PubMed ID: 11860537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tubal origin of 'ovarian' low-grade serous carcinoma.
    Li J; Abushahin N; Pang S; Xiang L; Chambers SK; Fadare O; Kong B; Zheng W
    Mod Pathol; 2011 Nov; 24(11):1488-99. PubMed ID: 21701538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 5. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors].
    Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y
    Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage-specific embryonic antigen 4 expression in epithelial ovarian carcinoma.
    Ye F; Li Y; Hu Y; Zhou C; Hu Y; Chen H
    Int J Gynecol Cancer; 2010 Aug; 20(6):958-64. PubMed ID: 20683402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological study of metallothionein immunohistochemical expression, in benign, borderline and malignant ovarian epithelial tumors.
    Zagorianakou N; Stefanou D; Makrydimas G; Zagorianakou P; Briasoulis E; Karavasilis V; Pavlidis N; Agnantis NJ
    Histol Histopathol; 2006 Apr; 21(4):341-7. PubMed ID: 16437378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma].
    Zhao RJ; Wang YY; Li Z; Wu KY; Kong LF; Zheng WX
    Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):542-547. PubMed ID: 28810294
    [No Abstract]   [Full Text] [Related]  

  • 9. Alpha(v)beta(6) integrin-A marker for the malignant potential of epithelial ovarian cancer.
    Ahmed N; Riley C; Rice GE; Quinn MA; Baker MS
    J Histochem Cytochem; 2002 Oct; 50(10):1371-80. PubMed ID: 12364570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of folate receptor alpha in ovarian epithelial tumors].
    Shen DH; Xie JL; Zhang YL; Wang Y
    Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):747-51. PubMed ID: 21215165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptotic and proliferative activity in ovarian benign, borderline and malignant tumors.
    Liu A; Chen L; Ngan HY; Khoo US; Zhao Y; Cheung AN
    Chin Med Sci J; 2002 Jun; 17(2):106-11. PubMed ID: 12906164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2.
    Brun JL; Cortez A; Commo F; Uzan S; Rouzier R; Daraï E
    Int J Oncol; 2008 Dec; 33(6):1239-46. PubMed ID: 19020757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prohibitin as a novel target protein of luteinizing hormone in ovarian epithelial carcinogenesis.
    Jia L; Yi XF; Zhang ZB; Zhuang ZP; Li J; Chambers SK; Kong BH; Zheng W
    Neoplasma; 2011; 58(2):104-9. PubMed ID: 21275458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal Proliferations in Completely Examined Fallopian Tubes Accompanying Ovarian Low-grade Serous Tumors: Neoplastic Precursor Lesions or Normal Variants of Benign Mucosa?
    Wolsky RJ; Price MA; Zaloudek CJ; Rabban JT
    Int J Gynecol Pathol; 2018 May; 37(3):262-274. PubMed ID: 28700429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
    Ramalingam P
    Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocalyxin-like protein 1 expression and correlation with clinical characteristics in epithelial serous and mucinous ovarian carcinoma and tumor-like lesions.
    Ye F; Hu Y; Zhou C; Hu Y; Chen H
    Pathobiology; 2012; 79(6):307-13. PubMed ID: 22688257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers.
    Mackenzie R; Talhouk A; Eshragh S; Lau S; Cheung D; Chow C; Le N; Cook LS; Wilkinson N; McDermott J; Singh N; Kommoss F; Pfisterer J; Huntsman DG; Köbel M; Kommoss S; Gilks CB; Anglesio MS
    Am J Surg Pathol; 2015 Nov; 39(11):1548-57. PubMed ID: 26099008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Polypeptide
    Murakami M; Kagami S; Nguyen TT; Koi C; Kurita T; Hachisuga T
    Anticancer Res; 2017 Jul; 37(7):3911-3915. PubMed ID: 28668894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid.
    Ahmed N; Riley C; Oliva K; Stutt E; Rice GE; Quinn MA
    J Pathol; 2003 Oct; 201(2):229-37. PubMed ID: 14517840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prohibitin: targeting peptide coupled to ovarian cancer, luteinization and TGF-β pathways.
    El-Etreby NM; Ghazy AA; Rashad R
    J Ovarian Res; 2017 Apr; 10(1):28. PubMed ID: 28427435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.